Discover 1,397 paid clinical trials in Cleveland, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,397
Sugammadex Vs Neostigmine in Reversing Neuromuscular Blocks in Outpatient ERCP. A Randomized, Double-Blinded Trial
for
Neuromuscular Blocks
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18+
Code: NCT06136585
Phase3, Recruiting
Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
for
Colorectal Cancer, Liver Metastases, Liver Cancer
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT07044362
Recruiting
Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation
for
Allogeneic Hematopoietic Cell Transplantation
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT04332341
Early_phase1, Recruiting
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
for
Irritability Associated With Autism Spectrum Disorder
Location: Garfield OH, Elgin IL, Petersburg VA, Nashville TN,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 5 - 17
Code: NCT06690398
Phase3, Recruiting
Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes
for
Tardive Dyskinesia
Location: Garfield Heights OH, Brooklyn NY
Sponsor: iRxReminder
Sex: All
Age: 18+
Code: NCT06011408
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: Canton OH, Garden City MI, Butler PA, Sarnia,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase3, Recruiting
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
for
Castration-Resistant Prostate Carcinoma,
Location: Warren OH, Youngstown OH, Boardman OH,
Sponsor: SWOG Cancer Research Network
Sex: Male
Age: 18+
Code: NCT06470243
Phase3, Recruiting
A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Canton OH, Lexington KY, Plantation FL
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Sex: All
Age: 18 - 70+
Code: NCT06592638
Phase1, Recruiting
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
for
Tardive Dyskinesia
Location: Garfield Heights OH, Grand Rapids MI, Naperville IL,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT03062033
Recruiting
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: Garfield OH, Westlake OH, Avon Lake OH,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers
for
Diabetic Foot Ulcer
Location: Clevland OH
Sponsor: Organogenesis
Sex: All
Age: 18+
Code: NCT06618612
Recruiting
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
for
Acute Treatment of Migraine
Location: Cleveland OH, Royal Oak MI, Ann Arbor MI, Amherst NY,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04743141
Phase3, Recruiting
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In